Join us for a quick overview of Alcon, a Ophthalmic Goods company whose shares moved 0.8% today. Here are some facts about the stock that should help you see the bigger picture:
-
Alcon has moved -11.1% over the last year, and the S&P 500 logged a change of -5.4%
-
ALC has an average analyst rating of buy and is -14.87% away from its mean target price of $83.55 per share
-
Its trailing earnings per share (EPS) is $0.67
-
Alcon has a trailing 12 month Price to Earnings (P/E) ratio of 106.2 while the S&P 500 average is 15.97
-
Its forward earnings per share (EPS) is $2.95 and its forward P/E ratio is 24.1
-
The company has a Price to Book (P/B) ratio of 1.8 in contrast to the S&P 500's average ratio of 2.95
-
Alcon is part of the Health Care sector, which has an average P/E ratio of 24.45 and an average P/B of 4.16
-
The company has a free cash flow of $866,750,016.00, which refers to the total sum of all its inflows and outflows of cash over the last quarter
-
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures.